Intravenous Glucose Tolerance Test in Cancer Patients
Author Information
Author(s): D. H. A. Boyd, Brigid Clapp, Maureen Finnegan
Primary Institution: Department for Endocrine and Metabolic Disease, Western General Hospital, Edinburgh
Hypothesis
The study aims to assess the incidence and severity of carbohydrate metabolism disorders in malignant disease and the effect of treatment on these abnormalities.
Conclusion
The study found that 50% of cancer patients had diminished glucose tolerance, which improved after treatment with oestrogens.
Supporting Evidence
- 50% of cancer patients showed diminished glucose tolerance.
- After treatment with oestrogens, glucose tolerance improved in six patients.
- The study compared results with previous studies showing varying rates of glucose tolerance issues in cancer patients.
Takeaway
Some cancer patients have trouble processing sugar, but treatment can help them get better at it.
Methodology
The study involved two groups: 19 control patients and 18 cancer patients, with glucose tolerance tests performed before and after treatment.
Potential Biases
Potential biases may arise from the small number of cases and the specific types of cancer studied.
Limitations
The study had a relatively small sample size and may not represent all cancer patients.
Participant Demographics
The study included 19 control patients and 18 patients with recurrent or metastatic mammary carcinoma, all at least five years past menopause.
Statistical Information
P-Value
0.01-0.005
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website